Home19X • FRA
add
Axsome Therapeutics Inc
Previous close
€96.08
Day range
€87.80 - €96.56
Year range
€59.56 - €135.55
Market cap
5.42B USD
Avg Volume
29.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 121.46M | 61.95% |
Operating expense | 167.14M | 21.66% |
Net income | -59.41M | 13.08% |
Net profit margin | -48.91 | 46.34% |
Earnings per share | -1.22 | 15.28% |
EBITDA | -53.34M | 20.22% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 300.91M | -9.21% |
Total assets | 596.67M | 9.33% |
Total liabilities | 543.47M | 35.29% |
Total equity | 53.20M | — |
Shares outstanding | 49.24M | — |
Price to book | 88.96 | — |
Return on assets | -23.80% | — |
Return on capital | -53.92% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -59.41M | 13.08% |
Cash from operations | -43.38M | 18.88% |
Cash from investing | -338.00K | -244.90% |
Cash from financing | 29.27M | 2,565.88% |
Net change in cash | -14.44M | 73.62% |
Free cash flow | -21.40M | 28.82% |
About
Founded
2012
Website
Employees
712
